Yes Pivalde, I agree that we might achieve success in combatting Parkinson's too but first things first. Complete our clinical trial(s) with ATH434 for MSA, get world-wide regulatory approvals, get the product to market ASAP, and generate some well deserved revenue for the Company and we long-suffering shareholders. Who's to say that ATH 434 won't be prescribed and used "off label" by Parkinson's afflicted individuals hopefully with positive results. Only then should we be willing and able to commence any Clinical Trials with a proven drug to see how effective it might be for early stage Parkinson's and so forth.
O
- Forums
- ASX - By Stock
- Lancet: NLY01 does not work in PD
Yes Pivalde, I agree that we might achieve success in combatting...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.42M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $113.4K | 18.91M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
60 | 62614132 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 3049506 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 62614132 | 0.005 |
59 | 71509382 | 0.004 |
52 | 50331648 | 0.003 |
15 | 32945514 | 0.002 |
13 | 94865101 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 3049506 | 2 |
0.007 | 16412773 | 18 |
0.008 | 21425596 | 29 |
0.009 | 11294412 | 13 |
0.010 | 3740594 | 9 |
Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
Last
0.6¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.6¢ | 0.6¢ | 0.6¢ | 3890928 | ||
Last updated 15.43pm 29/04/2024 ? |
Featured News
ATH (ASX) Chart |